Geoff Martha, Medtronic CEO
September 21, 2022 02:39 PM EDT
Pharma
FDA+

Some Medtron­ic in­sulin pumps are vul­ner­a­ble to hack­ers, FDA warns

Nicole DeFeudis

Editor

One of the fea­tures Medtron­ic touts in its Min­iMed 600 se­ries in­sulin pumps is a se­ries of com­po­nents that con­nect wire­less­ly to al­low the re­mote …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times